Aadi bioscience announces publication of its phase 2 registrational (ampect) trial of nab-sirolimus in patients with malignant perivascular epithelioid cell tumors in the journal of clinical oncology

Results published from first clinical trial in this rare disease results published from first clinical trial in this rare disease

AADI Ratings Summary

AADI Quant Ranking